| Financial Year |
March 31 2023 |
| Monetary Funds |
5,388,084,769.27 |
| Held-for-trading Financial Assets |
1,563,524,695.83 |
| Notes Receivable |
-- |
| Accounts Receivable |
169,068,782.56 |
| Advances to Suppliers |
56,913,912.33 |
| Other Receivables |
3,626,074.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
819,031,210.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
239,729,183.78 |
| Total Current Assets |
8,239,978,629.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
63,568,041.60 |
| Investment Properties |
539,253,588.62 |
| Fixed Assetes |
536,352,541.07 |
| Under-construction Projects |
127,308,887.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
128,666,481.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
82,788,349.39 |
| Deferred Income Tax Assets |
86,384,856.66 |
| Other Non-Current Assets |
3,975,438.41 |
| Sub-Total of Non-Current Assets |
2,279,702,823.55 |
| Total Assets |
10,519,681,452.88 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
126,626,029.74 |
| Accounts Received In Advance |
68,715.54 |
| Employee Compensation Payable |
107,084,128.28 |
| Taxes Payable |
111,814,669.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
43,068,332.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,667,904.03 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
423,310,256.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,261,362.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
114,841,074.61 |
| Total Liabilities |
538,151,330.78 |
| Paid-In Capital(Or Share Stock) |
1,136,078,141.00 |
| Capital Surplus |
5,412,181,063.43 |
| Surplus Reserve |
235,957,986.28 |
| LESS:Treasury Stock |
300,083,330.38 |
| Undistributed Profits |
3,405,874,534.09 |
| Minority Stockholder's Interest |
15,068,672.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,966,461,450.00 |
| Owner's Equity（Stockholder's Equity） |
9,981,530,122.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,519,681,452.88 |
